Volume 29, Issue 11 | Annals of Surgical Oncology

Search all Annals of Surgical Oncology articles

Volume 29, Issue 11

October 2022

149 articles in this issue

ASO Visual Abstract: Management of Malignant Small Bowel Obstruction—Is Intestinal Bypass Effective Palliation?
Meagan Read
Benjamin D. Powers
Sean P. Dineen
ASO Visual Abstract 01 August 2022 Pages: 6990 - 6990
Recursive Partitioning to Determine Order of Significance of Regional Metastasis Characteristics in Head and Neck Cutaneous Squamous Cell Carcinoma
Michael J. L. Hurrell
Gillian Z. Heller
Tsu-Hui Low
Head and Neck Oncology 15 May 2022 Pages: 6991 - 6999
ASO Visual Abstract: Recursive Partitioning to Determine Order of Significance of Regional Metastasis Characteristics in Head and Neck Cutaneous Squamous Cell Carcinoma
Michael J. L. Hurrell
Gillian Z. Heller
Tsu-Hui Low
ASO Visual Abstract 30 July 2022 Pages: 7000 - 7001
Team-Based Surgical Scheduling for Improved Patient Access in a High-Volume, Tertiary Head and Neck Cancer Center
Nicole C. Schmitt
Martha Ryan
Mark W. El-Deiry
Head and Neck Oncology 16 July 2022 Pages: 7002 - 7006
ASO Visual Abstract: Team-Based Surgical Scheduling for Improved Patient Access in a High-Volume, Tertiary Head and Neck Cancer Center
Nicole C. Schmitt
Martha Ryan
Mark W. El-Deiry
ASO Visual Abstract 27 July 2022 Pages: 7007 - 7008
Correction to: Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study
Konstantin S. Leppelmann
Vincent M. Levesque
Florian J. Fintelmann
Correction 17 February 2022 Pages: 7009 - 7009
Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration
Richard J. B. Walker
Nicole J. Look Hong
Michail N. Mavros
Melanoma 08 June 2022 Pages: 7010 - 7017
ASO Visual Abstract: Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma—An International Multi-institutional Collaboration
Richard J. B. Walker
Nicole J. Look Hong
Michail N. Mavros
ASO Visual Abstract 09 July 2022 Pages: 7018 - 7018
Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases
Anna K. Lawless
David J. Coker
Robyn P. M. Saw
Melanoma Open access 30 June 2022 Pages: 7019 - 7028
ASO Author Reflections: What Is the Role of Surgery in Management of In-Transit Melanoma in the Modern Era?
Anna K. Lawless
David J. Coker
Robyn P. M. Saw
ASO Author Reflections 19 July 2022 Pages: 7029 - 7030
ASO Visual Abstract: Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-transit Melanoma Metastases
Anna K. Lawless
David J. Coker
Robyn P. M. Saw
ASO Visual Abstract 22 August 2022 Pages: 7031 - 7032
An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma
Adrienne B. Shannon
Richard J. Straker III
John T. Miura
Melanoma 22 July 2022 Pages: 7033 - 7044
ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma
Adrienne B. Shannon
Richard J. Straker III
John T. Miura
ASO Visual Abstract 27 July 2022 Pages: 7045 - 7046
Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail
Kei Kitamura
Minoru Esaki
Kazuaki Shimada
Pancreatic Tumors 12 June 2022 Pages: 7047 - 7058
ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail
Kei Kitamura
Minoru Esaki
Kazuaki Shimada
ASO Author Reflections 01 June 2022 Pages: 7059 - 7060
ASO Visual Abstract: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail
Kei Kitamura
Minoru Esaki
Kazuaki Shimada
ASO Visual Abstract 28 June 2022 Pages: 7061 - 7062
The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer
Giovanni Guarneri
Diego Palumbo
Massimo Falconi
Pancreatic Tumors 18 June 2022 Pages: 7063 - 7073
ASO Author Reflections: The Impact of CT-assessed Liver Steatosis on Postoperative Complications after Pancreaticoduodenectomy for Cancer
Nicolò Pecorelli
Giovanni Guarneri
Massimo Falconi
ASO Author Reflections 07 June 2022 Pages: 7074 - 7075
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer
Giovanni Guarneri
Diego Palumbo
Massimo Falconi
ASO Visual Abstract 15 July 2022 Pages: 7076 - 7076
Commentary on “Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer”
Ning Pu
Hanlin Yin
Wenhui Lou
Pancreatic Tumors 07 July 2022 Pages: 7077 - 7078
Response to: Commentary on: “Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer”
T. J. Schouten
L. A. Daamen
I. Q. Molenaar
Pancreatic Tumors 04 August 2022 Pages: 7079 - 7080
Comparison of Reconstruction Techniques Following Sacroiliac Tumor Resection: A Systematic Review
Athan G. Zavras
Michael P. Fice
Matthew W. Colman
Reconstructive Oncology 29 July 2022 Pages: 7081 - 7091
Sentinel Lymph Node Biopsy and Formal Lymphadenectomy for Soft Tissue Sarcoma: A Single Center Experience of 86 Consecutive Cases
Russell G. Witt
Brandon Cope
Emily Z. Keung
Sarcoma 30 April 2022 Pages: 7092 - 7100
ASO Author Reflections: Lymph Node Disease in Soft Tissue Sarcoma: A Problematic Clinical Dilemma
Russell G. Witt
Christina L. Roland
Emily Z. Keung
ASO Author Reflections 29 April 2022 Pages: 7101 - 7101
ASO Visual Abstract: Sentinel Lymph Node Biopsy and Formal Lymphadenectomy For Soft Tissue Sarcoma: A Single-Center Experience of 86 Consecutive Cases
Russell G. Witt
Brandon Cope
Emily Z. Keung
ASO Visual Abstract 29 May 2022 Pages: 7102 - 7103
Use of Neoadjuvant Imatinib to Facilitate Minimally Invasive Resection of Gastric Gastrointestinal Stromal Tumors
George Z. Li
Mark Fairweather
Jiping Wang
Sarcoma 27 May 2022 Pages: 7104 - 7113
ASO Visual Abstract: Use of Neoadjuvant Imatinib to Facilitate Minimally Invasive Resection of Gastric Gastrointestinal Stromal Tumors
George Z. Li
Mark Fairweather
Jiping Wang
ASO Visual Abstract 11 July 2022 Pages: 7114 - 7114
Feasibility of Preoperative Dose-Painting Intensity Modulated Radiation Therapy (IMRT) for Borderline-Resectable Primary Retroperitoneal Sarcoma
Minsi Zhang
Aimee Crago
Kaled Alektiar
Sarcoma 30 June 2022 Pages: 7115 - 7121
ASO Visual Abstract: Feasibility of Preoperative Dose-Painting Intensity-Modulated Radiation Therapy (IMRT) for Borderline Resectable Primary Retroperitoneal Sarcoma
Minsi Zhang
Aimee Crago
Kaled Alektiar
ASO Visual Abstract 24 August 2022 Pages: 7122 - 7122
Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal Tumors
Thomas L. Sutton
Brett S. Walker
Skye C. Mayo
Sarcoma 12 July 2022 Pages: 7123 - 7132
ASO Visual Abstract: Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal Tumors
Thomas L. Sutton
Brett S. Walker
Skye C. Mayo
ASO Visual Abstract 29 July 2022 Pages: 7133 - 7133
Correction to: Non-Private Health Insurance Predicts Advanced Stage at Presentation and Amputation in Lower Extremity High Grade Bone Sarcoma: A National Cancer Database Study
Muhammad Umar Jawad
Brad H. Pollock
Steven W. Thorpe
Correction 15 April 2022 Pages: 7134 - 7134
Versican Secreted by Cancer-Associated Fibroblasts is a Poor Prognostic Factor in Hepatocellular Carcinoma
Koichi Kato
Moto Fukai
Akinobu Taketomi
Translational Research 11 May 2022 Pages: 7135 - 7146
ASO Visual Abstract: Versican Secreted by Cancer-Associated Fibroblasts Is a Poor Prognostic Factor in Hepatocellular Carcinoma
Koichi Kato
Moto Fukai
Akinobu Taketomi
ASO Visual Abstract 28 July 2022 Pages: 7147 - 7148
RAB11A Expression Is Associated With Cancer Aggressiveness Through Regulation of FGFR-Signaling in Lung Squamous Cell Carcinoma
Navchaa Gombodorj
Yoko Azuma
Ken Shirabe
Translational Research 29 May 2022 Pages: 7149 - 7162
ASO Visual Abstract: RAB11A Expression is Associated with Cancer Aggressiveness Through Regulation of FGFR-Signaling in Lung Squamous Cell Carcinoma
Navchaa Gombodorj
Yoko Azuma
Ken Shirabe
ASO Visual Abstract 23 May 2022 Pages: 7163 - 7164
A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer
Guan-Hua Su
Lin Jiang
Chao You
Translational Research 16 June 2022 Pages: 7165 - 7175
ASO Author Reflections: Deeper Insight into Therapeutic Implications and Non-invasive Detection of Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Results from a Multi-omics Cohort Study
Guan-Hua Su
Lin Jiang
Chao You
ASO Author Reflections 29 May 2022 Pages: 7176 - 7177
ASO Visual Abstract: A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer
Guan-Hua Su
Lin Jiang
Chao You
ASO Visual Abstract 15 July 2022 Pages: 7178 - 7179
Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9
Masaya Yamanaka
Masamichi Hayashi
Yasuhiro Kodera
Translational Research 20 June 2022 Pages: 7180 - 7189
ASO Author Reflections: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9
Masaya Yamanaka
Masamichi Hayashi
Yasuhiro Kodera
ASO Author Reflections 29 June 2022 Pages: 7190 - 7191
ASO Visual Abstract: Downregulation of ROBO4 in Pancreatic Cancer Serves as a Biomarker of Poor Prognosis and Indicates Increased Cell Motility and Proliferation Through Activation of MMP-9
Masaya Yamanaka
Masamichi Hayashi
Yasuhiro Kodera
ASO Visual Abstract 02 July 2022 Pages: 7192 - 7193
Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer
Meghan R. Flanagan
David R. Doody
Vijayakrishna K. Gadi
Translational Research 01 July 2022 Pages: 7194 - 7201
ASO Author Reflections: Inheritance of Adrenal Permissive HSD3B1 Genotype Negatively Impacts Outcomes in Hormone Receptor-Positive Postmenopausal Breast Cancer
Meghan R. Flanagan
Nima Sharifi
Vijayakrishna K. Gadi
ASO Author Reflections 11 July 2022 Pages: 7202 - 7203
ASO Visual Abstract: Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen Receptor-Positive Breast Cancer
Meghan R. Flanagan
David R. Doody
Vijayakrishna K. Gadi
ASO Visual Abstract 18 August 2022 Pages: 7204 - 7205
Anti-Androgen Therapy Overcomes the Time Delay in Initiation of Salvage Radiation Therapy and Rescues the Oncological Outcomes in Men with Recurrent Prostate Cancer After Radical Prostatectomy: A Post Hoc Analysis of the RTOG-9601 Trial Data
Akshay Sood
Jacob Keeley
Firas Abdollah
Urologic Oncology 24 May 2022 Pages: 7206 - 7215
ASO Visual Abstract: Anti-androgen Therapy Overcomes the Time Delay in Initiation of Salvage Radiation Therapy and Rescues the Oncological Outcomes in Men with Recurrent Prostate Cancer After Radical Prostatectomy—A Post Hoc Analysis of the RTOG 9601 Trial Data
Akshay Sood
Jacob Keeley
Firas Abdollah
ASO Visual Abstract 30 May 2022 Pages: 7216 - 7217
Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82)
Thomas Tabourin
Ugo Pinar
Morgan Roupret
Urologic Oncology 03 July 2022 Pages: 7218 - 7228
ASO Visual Abstract: Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-institutional, Prospective Study (UROCCR Study 82)
Thomas Tabourin
Ugo Pinar
Morgan Roupret
ASO Visual Abstract 21 August 2022 Pages: 7229 - 7230